Antioxidant and Osmoprotecting Activity of Taurine in Dry Eye Models
Authors:
- 1 March 2018
- journal article
- research article
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 34 (1-2) , 188-194
Abstract
Purpose: To assess the protective effects of ophthalmic formulations based on taurine (TAU) and sodium hyaluronate (SH) in ocular surface. Methods: Rabbit corneal epithelial cells [Statens Seruminstitut Rabbit Cornea (SIRC)] were subjected to oxidative stress (1 mM H2O2) and treated with the following formulations: 0.2% SH, 0.4% SH, 0.4% SH +0.5% TAU. Reactive oxygen species (ROS) were evaluated by commercial kit. Dry eye was induced by atropine sulfate and topical treatment was carried out with the following formulations: 0.2% SH, 0.4% SH, 0.4% SH +0.5% TAU. Schirmer's test, tear breakup time (TBUT), and tear osmolarity were evaluated. Furthermore, tear matrix metalloproteinase 9 (MMP-9) expression was assessed by Western blot. Results: TAU significantly (P < 0.05) decreased ROS production in SIRC after oxidative stress. Topical administration of atropine in the rabbit eye significantly (P < 0.05) reduced tear volume and TBUT. Tear osmolarity was also significantly (P < 0.05) modified by atropine treatment. All the altered parameters were significantly (P < 0.05) reversed by 0.5% TAU +0.4% SH treatment; furthermore, this formulation was more effective than SH alone. Moreover, tear levels of MMP-9 were significantly (P < 0.05) lower in the group treated with 0.5% TAU +0.4% SH. Conclusions: Altogether these data suggest that TAU has a relevant antioxidant effect in corneal epithelial cells and prevents the ocular surface damage elicited by atropine. Therefore, our findings suggest that TAU in combination with SH may be useful in clinical practice to manage ocular surface diseases.Keywords
This publication has 38 references indexed in Scilit:
- Dry Eye DiseaseArchives of Ophthalmology (1950), 2012
- In Vivo Ocular Efficacy Profile of Mapracorat, a Novel Selective Glucocorticoid Receptor Agonist, in Rabbit Models of Ocular DiseaseInvestigative Ophthalmology & Visual Science, 2011
- Efficacy of topically applied liposome‐bound tetracycline in the treatment of dry eye modelVeterinary Ophthalmology, 2011
- Efficacy of different dry eye treatments with artificial tears or ocular lubricants: a systematic reviewOphthalmic and Physiological Optics, 2009
- Production and Activity of Matrix Metalloproteinase-9 on the Ocular Surface Increase in Dysfunctional Tear SyndromeInvestigative Ophthalmology & Visual Science, 2009
- Effects of DA-6034 on Aqueous Tear Fluid Secretion and Conjunctival Goblet Cell ProliferationJournal of Ocular Pharmacology and Therapeutics, 2009
- Comparison between two cyclooxygenase inhibitors in an experimental dry eye model in albino rabbitsActa Pharmaceutica, 2008
- Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cellsArthritis & Rheumatism, 2006
- Quantitative Evaluation of the Effectiveness of Taurine in Protecting the Ocular Surface against Oxident.Chemical and Pharmaceutical Bulletin, 1993
- Plasma amino-acids in hereditary retinal disease. Ornithine, lysine, and taurine.British Journal of Ophthalmology, 1976